HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double filtration plasmapheresis in a patient with autoimmune hepatitis-systemic lupus erythematosus overlap.

Abstract
Double filtration plasmapheresis (DFPP) therapy was administered to a patient with autoimmune hepatitis (AIH)-systemic lupus erythematosus overlap. The patient had suffered from recurrent AIH attacks with an interval of 3-4 months despite massive corticosteroid administration. After vigorous removal of immunoglobulins by DFPP procedures combined with immunosuppressive therapies, clinical and laboratory findings of AIH were remarkably improved. DFPP might be an optional modality in the treatment of AIH patients, especially for those who are resistant to and/or cannot tolerate massive corticosteroid or immunosuppressive therapies.
AuthorsK Suzuki, Y Matsuki, T Hidaka, Y Kawaguchi, M Kawakami, K Hino, H Nakamura
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 32 Issue 9 Pg. 725-9 (Sep 1993) ISSN: 0918-2918 [Print] Japan
PMID8142679 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin G
Topics
  • Adult
  • Autoimmune Diseases (complications, immunology, therapy)
  • Female
  • Hepatitis (complications, immunology, therapy)
  • Humans
  • Hypergammaglobulinemia (complications, immunology, therapy)
  • Immunoglobulin G (blood)
  • Lupus Erythematosus, Systemic (complications, immunology, therapy)
  • Plasmapheresis (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: